Regeneron Pharmaceuticals’s Adverum Biotechnologies ADVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$389K Hold
180,909
0.03% 4
2025
Q1
$791K Hold
180,909
0.06% 4
2024
Q4
$845K Buy
+180,909
New +$845K 0.08% 5